There are currently no treatments that cure or slow Alzheimer's. Now, for the first time since scientists recently agreed that the cause most likely lies in toxic clumps of oligomer protein, a strategy for creating drugs to target them has emerged.

Alzheimer's, which is a neurological condition, gradually kills brain cells.

This plan is the result of joint work between the University of Cambridge in the United Kingdom and Lund University in Sweden.

A paper about the study is shortly to appear in Proceedings of the National Academy of Sciences.